Outlive the Average
Quick, actionable longevity insights delivered weekly.
May 12, 2025 · 6 min
This week’s longevity news brings exciting advances for busy professionals focused on maximizing health efficiently. A large international trial reveals that weekly semaglutide injections can reverse liver fibrosis and resolve metabolic-associated steatohepatitis, offering hope against a common but serious condition. Meanwhile, gene therapy delivering the anti-aging protein klotho extended mouse lifespans nearly 20%, enhancing muscle, bone, and cognitive functions. Supplement-wise, Wonderfeel launched a high-dose NMN formula designed to boost cellular NAD+ levels—a key factor in energy production and aging. On the tech front, Whoop’s 5.0 wearable enhances healthspan tracking with longer battery life and medical-grade biometrics. Practical lifestyle insights arrive from Tom Cruise’s trainer with science-backed longevity habits, and personalized female-focused biohacking routines highlight how aligning technology with biology can personalize aging strategies. Together, these developments underscore a multidimensional and accessible approach to aging well.A groundbreaking trial shows semaglutide not only resolves steatohepatitis in nearly 63% of patients but also significantly reduces liver fibrosis, marking a pivotal shift toward actual tissue repair in fatty liver disease and opening doors to fewer complications and longer healthspan.
An international, double-blind, placebo-controlled trial at 253 sites demonstrates that weekly subcutaneous semaglutide (2.4 mg) resolves steatohepatitis in 62.9% of patients and reduces fibrosis in 36.8%. The study assesses histological endpoints via liver biopsies at baseline and week 72, offering a promising pharmacological strategy against metabolic dysfunction-associated steatohepatitis.
Key points:
Why it matters: These findings shift the treatment paradigm for advanced fatty liver disease by demonstrating histological reversal rather than merely symptom relief. Semaglutide’s dual modulation of hepatic inflammation and systemic metabolism offers a multifunctional therapeutic approach that could prevent progression to cirrhosis and decrease cardiometabolic complications.
A team at the University of Barcelona employs adeno-associated virus serotype 9 to deliver the Klotho gene in adult mice. The single-dose treatment elevates s-KL protein levels systemically and in the brain, yielding nearly 20% longer lifespans alongside preserved muscle function, bone volume and cognitive resilience. Their findings illustrate a multi-organ anti-aging approach targeting fundamental longevity processes rather than individual diseases.
Key points:
Why it matters: Targeting Klotho offers a unified, multi-tissue anti-aging approach that could transform longevity medicine beyond single-disease treatments.
The dietary supplement company Wonderfeel introduces its 900 mg NMN formulation, Youngr™, designed to elevate intracellular NAD+ levels and support cellular repair pathways. The clinical-strength blend combines NMN with complementary actives—trans-resveratrol, vitamin D3, olive fruit extract, and ergothioneine—to optimize antioxidant protection and metabolic energy.
Key points:
Why it matters: This high-potency formulation offers a scalable strategy to counteract age-related NAD+ decline, potentially transforming preventive longevity interventions.
Whoop, the wearables manufacturer, releases the 5.0 tracker with extended battery life, tiered subscriptions, Healthspan biomarker scores, and on-demand ECG via its MG model, refining its platform to focus on longevity and holistic health insights.
Key points:
Why it matters: This update positions Whoop at the forefront of longevity-focused wearables by combining extended battery life with actionable biomarker analytics previously limited to clinical settings.
Led by Tom Cruise’s longtime trainer, a nine-step regimen emphasizes dynamic stretching, strategic HIIT, precise hydration, anti-inflammatory nutrition, quality sleep, strength training, mindfulness, and cold exposure. Each practice targets cellular aging pathways—boosting synovial fluid, growth hormone, mitochondrial function, autophagy, and stress resilience—to support sustained vitality and slow biological aging across all fitness levels.
Key points:
Why it matters: By integrating simple, science-backed daily practices, this regimen offers a scalable strategy to delay aging and enhance long-term healthspan.
Katie Fry and the Revive Rejoice health editors present ten scientifically supported anti-aging foods, from extra virgin olive oil to pomegranates, explaining how their key nutrients and antioxidants combat oxidative stress and support collagen, brain, and cardiovascular health.
Key points:
Why it matters: Highlighting evidence-based dietary choices empowers individuals to leverage natural compounds for slowing cellular aging and reducing chronic disease risk.
Wellness entrepreneur Kayla Barnes collaborates with clinicians to implement a comprehensive biohacking regimen, employing technologies such as PEMF mats, Oura ring biometrics, red/blue light therapy, and hyperbaric oxygen. By customizing nutrition, exercise, and recovery protocols to menstrual cycles, this approach seeks to fortify bone density, optimize metabolic health, and slow age-related decline in women seeking personalized longevity solutions.
Key points:
Double your trial time to experience the full transformation.
This offer expires in 24 hours.